Pre-solicitationPosted Oct 14, 2026·Responses due Oct 30, 2026

Dose Reconstruction and Related Activities to Support NIOSH's Responsibilities under the Energy Employees Occupational Illness Compensation Act (EEOICPA)

CDC · CDC OFFICE OF ACQUISITION SERVICES

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
541990
Value
Not stated
Solicitation
0000HCCN-2027-99582
Set-aside
None stated
PSC
R499
Place
Atlanta, GA, USA
Contact
Taylor Wellman (xur0@cdc.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 0000HCCN-2027-99582 in this department, oldest first.

Early notice
  • Oct 14, 2026 · this notice
    Pre-solicitation
Solicitation
None posted
Award
Not yet. Too few past cases at this agency to estimate timing (2 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

PRESOLICITATION NOTICE Dose Reconstruction and Related Activities to Support NIOSH's Responsibilities under the Energy Employees Occupational Illness Compensation Act (EEOICPA) This presolicitation notice is prepared in accordance with Revolutionary FAR Overhaul 5.101. 1. Points of Contact H. Taylor Wellman, Contract Specialist Office of Acquisition Services Centers for Disease Control and Prevention Chamblee Campus Building 108 4770 Buford Highway Atlanta, GA 30341 Email: xur0@cdc.gov H. Dale Bish, Contracting Officer Office of Acquisition Services Centers for Disease Control and Prevention C… (show all)

hamblee Campus Building 108 4770 Buford Highway Atlanta, GA 30341 Email: uwo8@cdc.gov 2. Set-Asides This acquisition is currently unrestricted. All responsible sources, including small businesses and other than small business concerns, are encouraged to respond. 3. Codes for Services or Supplies North American Industry Classification System (NAICS) Code: 541990 � All Other Professional, Scientific, and Technical Services Product Service Code (PSC): R499 � Support-Professional: Other 4. Description (i) The Centers for Disease Control and Prevention (CDC), on behalf of the National Institute for Occupational Safety and Health (NIOSH), intends to solicit offers for Dose Reconstruction and Related Activities to Support NIOSH's Responsibilities under the Energy Employees Occupational Illness Compensation Act (EEOICPA). The anticipated contract will support NIOSH's Division of Compensation Analysis and Support (DCAS) in fulfilling its statutory obligations under EEOICPA by performing radiation dose reconstructions for claims referred by the Department of Labor (DOL) and evaluating petitions for additions of classes to the Special Exposure Cohort (SEC). The anticipated contract type is Cost Plus Award Fee (CPAF). The anticipated period of performance is March 1, 2027 through February 29, 2028 (base year), with four (4) twelve-month option periods through February 28, 2032. Work will be performed at the contractor's facility. The scope of work includes the following principal task areas: Identification of data relevant to reconstructing radiation doses and evaluating SEC petitions Claimant communications, including computer assisted telephone interviews Dose estimation and reporting Special Exposure Cohort petition evaluations Technical and program management support Operational continuity, cloud migration, and modernization of DCAS systems and processes Contractor personnel performing work under this contract will be required to obtain background investigations commensurate with a Level 5C Moderate Risk position sensitivity designation. Additionally, a reasonable number of contractor staff must possess or be able to obtain Department of Energy Q clearances to perform work under this contract. All contractor personnel must comply with applicable HHS and CDC information security policies. (ii) Not applicable. This acquisition is expected to exceed the simplified acquisition threshold. (iii) One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. (iv) All technical data required to respond will be provided as part of the solicitation. (v) Not applicable. This is not a construction contract. (vi) All responsible sources may submit a quotation, bid, or proposal, as appropriate, which will be considered by the agency. (vii) Not applicable. This acquisition is competitive. (viii) Contractor personnel performing work under this contract will be required to obtain background investigations commensurate with a Level 5C Moderate Risk position sensitivity designation. Additionally, a reasonable number of contractor staff must possess or be able to obtain Department of Energy Q clearances. Additional information regarding security requirements will be provided as part of the solicitation. Timing There is no solicitation available at this time. A solicitation is anticipated to be issued in November 2026.

Who won similar work

13 award notices on SAM.gov in the last 24 months. Matched by: Same office (CDC OFFICE OF ACQUISITION SERVICES), same product/service code (PSC) R499.

Single-winner award sizes (9): middle half $737K to $4.0M, median $2.2M; range $395K to $28.1M.

WinnerAwardsValueLast
STRATEGIC INNOVATIVE SOLUTIONS LLC2$1.2MMar 17, 2026
DECISIONPOINT CORPORATION1$28.1MSep 9, 2026
RESEARCH TRIANGLE INSTITUTE Durham NC 27709 USA1$6.5MJun 4, 2026
DELOITTE CONSULTING LLP1$4.0MAug 19, 2025
IMPLENOMICS LLCS Marblehead MA 01945 USA1$2.6MMar 17, 2026
DAVIS PROFESSIONAL SERVICES, LLC1$2.2MApr 23, 2026
WINDSOR GROUP LLC1$1.4MMar 4, 2026
POLOLEI SOLUTIONS, LLC1$395KMay 27, 2026
INBIOS INTERNATIONAL INC1– + 1 sharedJan 7, 2026
CEPHEID Sunnyvale CA 94089 USA1– + 1 sharedJan 7, 2026

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (0 filings)
  • 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.